SCHEMBL7570520

SCHEMBL7570520

Clc1c(-c2ccccn2)[c]ccc1-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 2/20 0.42
SMN1; SMN2 Q16637 6/20 0.40
RAB9A P51151 6/20 0.40
LMNA P02545 5/20 0.40
NPC1 O15118 5/20 0.40
HPGD P15428 3/20 0.40
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
KDM4E B2RXH2 6/20 0.39
CCR1 P32246 3/20 0.39
CCR5 P51681 3/20 0.39
CCR8 P51685 3/20 0.39
METAP1 P53582 2/20 0.39
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.39
BLM P54132 1/20 0.39
HIF1A Q16665 1/20 0.39
DOHH Q9BU89 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14783132 0.80 KDM4E (0.45) SMN1; SMN2RAB9ALMNANPC1HPGD
SCHEMBL7569351 0.79 TGFBR1 (0.45) TGFBR1SMN1; SMN2RAB9ALMNANPC1
SCHEMBL1033552 0.76 KDM4E (0.48) SMN1; SMN2RAB9ALMNANPC1HPGD
SCHEMBL5796609 0.75 KDM4E (0.39) TGFBR1SMN1; SMN2RAB9ALMNANPC1
SCHEMBL7265635 0.73 KDM4E (0.59) SMN1; SMN2RAB9ALMNANPC1HPGD
SCHEMBL7571214 0.72 KDM4E (0.43) TGFBR1SMN1; SMN2RAB9ALMNANPC1
SCHEMBL14782994 0.72 KDM4E (0.39) TGFBR1SMN1; SMN2RAB9ALMNANPC1
SCHEMBL6207069 0.70 CYP2A6 (0.43) RAB9ALMNANPC1HPGDCASP3
SCHEMBL14782863 0.70 KDM4E (0.41) TGFBR1SMN1; SMN2RAB9ALMNANPC1
SCHEMBL3363096 0.69 KDM4E (0.48) SMN1; SMN2RAB9ALMNANPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002089799-A2 USE OF DIHYDROPYRAZOLES TO INCREASE ERYTHROPOIETIN AND VASCULARI ZATION THE PROCTER & GAMBLE COMPANY (US) 2002-11-14 WO disclosed